Nondestructive quantification of analyte diffusion in cornea and sclera using optical coherence tomography

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 6, 2007, Pages 2726-2733

  Ghosn, Mohamad G ^a   Tuchin, Valery V ^b   Larin, Kirill V ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b SARATOV STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DEXAMETHASONE; GLUCOSE; MANNITOL; METRONIDAZOLE; WATER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; DIFFUSION COEFFICIENT; DRUG PENETRATION; EYEBALL; FLUID TRANSPORT; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL RESOLUTION; PRIORITY JOURNAL; RABBIT; SCLERA; SIGNAL TRANSDUCTION; SPECTRAL SENSITIVITY; ANIMAL; METABOLISM; METHODOLOGY; PERMEABILITY; PILOT STUDY; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CIPROFLOXACIN; CORNEA; DEXAMETHASONE; MANNITOL; METRONIDAZOLE; PERMEABILITY; PILOT PROJECTS; RABBITS; SCLERA; TISSUE DISTRIBUTION; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 34347244936     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1331     Document Type: Article

References (52)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Starr CE, Guyer DR, Yannuzzi LA. Age-related macular degeneration: can we stem this worldwide public health crisis? Postgrad Med. 1998;156:161-164.
3. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci. 2000;41:961-964.
4. Zhang WS, Prausnitz MR, Edwards A. Model of transient drug diffusion across cornea. J Control Release. 2004;99:241-258.
5. Davis JL, Gilger BC, Robinson MR. Novel approaches to ocular drug delivery. Curr Opin Mol Ther. 2004;6:195-205.
6. Kim JW, Lindsey JD, Wang N, Weinreb RN. Increased human scleral permeability with prostaglandin exposure. Invest Ophthalmol Vis Sci. 2001;42:1514-1521.
7. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41:1181-1185.
8. Okabe K, Kimura, Okabe J, et al. Effect of benzalkonium chloride on transscleral drug delivery. Invest Ophthalmol Vis Sci. 2005;46:703-708.
9. Kim TW, Lindsey JD, Aihara M, Anthony TL, Weinreb RN. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice. Invest Ophthalmol Vis Sci. 2002;43:1809-1816.
10. Lindsey JD, Weinreb RN. Identification of the mouse uveoscleral outflow pathway using fluorescent dextran. Invest Ophthalmol Vis Sci. 2002;43:2201-2205.
11. Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479-1488.
12. Kim H, Lizak MJ, Tansey G, et al. Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging. Ann Biomed Eng. 2005;33:150-164.
13. Li SK, Jeong EK, Hastings MS. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis. Invest Ophthalmol Vis Sci. 2004;45:1224-1231.
14. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
15. Fercher AF, Drexler W, Hitzenberger CK, Lasser T. Optical coherence tomography - principles and applications. Rep Prog Phys. 2003;66:239-303.
16. Podoleanu AG. Optical coherence tomography. Br J Radiol. 2005;78:976-988.
17. Boppart SA. Optical coherence tomography - principles, applications and advances. Minerva Biotec. 2004;16:211-237.
18. Storen T, Royset A, Svaasand LO, Lindmo T. Measurement of dye diffusion in scattering tissue phantoms using dual-wavelength low-coherence interferometry. J Biomed Opt. 2006;11:14-17.
19. Ghosn M, Tuchin VV, Larin KV. Depth-resolved monitoring of glucose diffusion in tissues by using optical coherence tomography. Optics Lett. 2006;31:2314-2316.
20. Tuchin VV, Maksimova IL, Zimnyakov DA, Kon IL, Mavlyutov AH, Mishin AA. Light propagation in tissues with controlled optical properties J Biomed Optics. 1997;2:401-417.
21. Esenaliev RO, Larin KV, Larina IV, Motamedi M. Noninvasive monitoring of glucose concentration with optical coherence tomography. Opt Lett. 2001;26:992-994.
22. Larin KV, Eledrisi MS, Motamedi M, Esenaliev RO. Noninvasive blood glucose monitoring with optical coherence tomography-a pilot study in human subjects. Diabetes Care. 2002;25:2263-2267.
23. Larin KV, Motamedi M, Ashitkov TV, Esenaliev RO. Specificity of noninvasive blood glucose sensing using optical coherence tomography technique: a pilot study. Phys Med Biol. 2003;48:1371-1390.
24. Yeh AT, Hirshburg J. Molecular interactions of exogenous chemical agents with collagen - implications for tissue optical clearing (review). J Biomed Opt. 2006;11:014003.
25. Tuchin VV. Optical Clearing of Tissues and Blood. Bellingham, MA: SPIE Press; 2005.
26. Tuchin VV. Optical clearing of tissues and blood using the immersion method. J Phys D-Appl Phys. 2005;38:2497-2518.
27. Graaff R, Aarnoudse JG, Zijp JR, et al. Reduced light-scattering properties for mixtures of spherical particles-a simple approximation derived from Mie calculations. Appl Opt. 1992;31:1370-1376.
28. Larin KV, Akkin T, Esenaliev RO, Motamedi M, Milner TE. Phase-sensitive optical low-coherence reflectometry for the detection of analyte concentrations. Appl Opt. 2004;43:3408-3414.
29. Kinnunen M, Myllylä R, Jokela T, Vainio S. In vitro studies toward noninvasive glucose monitoring with optical coherence tomography. Appl Opt. 2006;45:2251-2260.
30. Wang RKK, Xu XQ, Tuchin VV, Elder JB. Concurrent enhancement of imaging depth and contrast for optical coherence tomography by hyperosmotic agents. J Opt Soc Am B-Opt Phys. 2001;18:948-953.
31. Tuchin VV, Xu XQ, Wang RK. Dynamic optical coherence tomography in studies of optical clearing, sedimentation, and aggregation of immersed blood. Appl Opt. 2002;41:258-271.
32. Grass GM, Robinson JR. Mechanisms of corneal drug penetration, I: in vivo and in vitro kinetics. J Pharm Sci. 1988;77:3-14.
33. Ke TL, Cagle G, Schlech B, Lorenzetti OJ, Mattern J. Ocular bioavailability of ciprofloxacin in sustained release formulations. J Ocul Pharmacol Ther. 2001;17:555-563.
34. Larin KV, Ghosn M. Influence of experimental conditions on drug diffusion in cornea. Quantum Electronics. 2006;36:1083-1088.
35. Li SK, Molokhia SA, Jeong EK. Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging. Pharm Res. 2004;21:2175-2184.
36. Bashkatov AN, Genina EA, Sinichkin YP, Kochubei VI, Lakodina NA, Tuchin VV. Estimation of the glucosa diffusion coefficient in human eye sclera. Biophysics. 2003;48:292-296.
37. Pawar PK, Majumdar DK. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas. AAPS PharmSciTech. 2006;7:E13.
38. Pfister RR, Burstein N. The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study. Invest Ophthalmol. 1976;15:246-259.
39. Rohde BH, Chiou GC. Effect of permeation enhancers on beta-endorphin systemic uptake after topical application to the eye. Ophthalmic Res. 1991;23:265-271.
40. Vizarova K, Bakos D, Rehakova M, Macho V. Modification of layered atelocollagen by ultraviolet irradiation and chemical cross-linking: structure stability and mechanical properties. Biomaterials. 1994;15:1082-1086.
41. deBoer JF, Milner TE, van Gemert MJC, Nelson JS. Two-dimensional birefringence imaging in biological tissue by polarization-sensitive optical coherence tomography. Opt Lett. 1997;22:934-936.
42. Drexler W, Stamper D, Jesser C, et al. Correlation of collagen organization with polarization sensitive imaging of in vitro cartilage: implications for osteoarthritis. J Rheumatol. 2001;28:1311-1318.
43. Jiao SL, Yu WR, Stoica G, Wang LHV. Optical-fiber-based Mueller optical coherence tomography. Opt Lett. 2003;28:1206-1208.
44. Applegate BE, Yang CH, Rollins AM, Izatt JA. Polarization-resolved second-harmonic-generation optical coherence tomography in collagen. Opt Lett. 2004;29:2252-2254.
45. Farrell RA, McCally RL. Corneal transparency. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia, PA: WB Saunders; 2000.
46. Elliott GF, Goodfellow JM, Woolgar AE. Swelling studies of bovine corneal stroma without bounding membranes. J Physiol. 1980;298:453-470.
47. Hodson S, Kaila D, Hammond S, Rebello G, al-Omari Y. Transient chloride binding as a contributory factor to corneal stromal swelling in the ox. J Physiol. 1992;450:89-103.
48. Maurice DM. The cornea and the sclera. In: Davson H, ed. The Eye. New York: Academic Press; 1969.
49. Boubriak OA, Urban JP, Akhtar S, Meek KM, Bron AJ. The effect of hydration and matrix composition on solute diffusion in rabbit sclera. Exp Eye Res. 2000;71:503-514.
50. Komai Y, Ushiki T. The three-dimensional organization of collagen fibrils in the human cornea and sclera. Invest Ophthalmol Vis Sci. 1991;32:2244-2258.
51. Jiang J, Geroski DH, Edelhauser HF, Prausnitz MR. Measurement and prediction of lateral diffusion within human sclera. Invest Ophthalmol Vis Sci. 2006;47:3011-3016.
52. Lyubovitsky JG, Spencer JA, Krasieva TB, Andersen B, Tromberg BJ. Imaging corneal pathology in a transgenic mouse model using nonlinear microscopy. J Biomed Opt. 2006;11:14013.